Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Sinar Eka Selaras Tbk. (ERAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Sinar Eka Selaras Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B), while Sinar Eka Selaras Tbk. trades at Rp284 (market cap 1.47T). The key difference: Sinar Eka Selaras Tbk. is far larger — about 4.8× Diagnos Laboratorium Utama Tbk.'s market cap. Which is the better fit depends on your goals.
| DGNS | ERAL | |
|---|---|---|
Market Cap | 308B | 1.47T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Sinar Eka Selaras Tbk.
PT Sinar Eka Selaras Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 12 of Myra Yuwono, S.H., dated March 13, 2009. PT Erajaya Swasembada Tbk, an entity incorporated in Indonesia, is the parent company of the Company. PT Eralink International, an entity incorporated inIndonesia, is the ultimate parent of the Company.
Read more on ERAL →
